Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

被引：0
|
作者：
Chen, James X. [1 ]
Rose, Steven [2 ]
White, Sarah B. [3 ]
El-Haddad, Ghassan [4 ]
Fidelman, Nicholas [5 ]
Yarmohammadi, Hooman [6 ]
Sze, Daniel [7 ]
Salem, Riad [8 ]
Metz, David [9 ]
Soulen, Michael C. [1 ]
机构：
[1] Hosp Univ Penn, Div Intervent Radiol, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ San Diego, Med Ctr, Div Intervent Radiol, Dept Radiol, San Diego, CA 92110 USA
[3] Univ Wisconsin, Sch Med, Div Intervent Radiol, Dept Radiol, Madison, WI USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Div Intervent Radiol, Dept Radiol, Tampa, FL USA
[5] Univ San Francisco, Med Ctr, Div Intervent Radiol, Dept Radiol, San Francisco, CA 94117 USA
[6] Mem Sloan Kettering Canc Ctr, Div Intervent Radiol, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[7] Stanford Univ, Med Ctr, Div Intervent Radiol, Dept Radiol, Stanford, CA 94305 USA
[8] NW Mem Hosp, Div Intervent Radiol, Dept Radiol, Chicago, IL 60611 USA
[9] Hosp Univ Penn, Div Gastroenterol, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [1] Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
    Chen, James X.
    Rose, Steven
    White, Sarah B.
    El-Haddad, Ghassan
    Fidelman, Nicholas
    Yarmohammadi, Hooman
    Hwang, Winifred
    Sze, Daniel Y.
    Kothary, Nishita
    Stashek, Kristen
    Wileyto, E. Paul
    Salem, Riad
    Metz, David C.
    Soulen, Michael C.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (01) : 69 - 80
  • [2] Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
    James X. Chen
    Steven Rose
    Sarah B. White
    Ghassan El-Haddad
    Nicholas Fidelman
    Hooman Yarmohammadi
    Winifred Hwang
    Daniel Y. Sze
    Nishita Kothary
    Kristen Stashek
    E. Paul Wileyto
    Riad Salem
    David C. Metz
    Michael C. Soulen
    CardioVascular and Interventional Radiology, 2017, 40 : 69 - 80
  • [3] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [4] Association of Progression-Free Survival With Overall Survival in Patients With Neuroendocrine Tumor Treated With Somatostatin Analogs
    Ter-Minassian, Monica
    Brooks, Nichole V.
    Brais, Lauren K.
    Chan, Jennifer A.
    Christiani, David C.
    Lin, Xihong
    Gabriel, Sylvie
    Dinet, Jerome
    Kulke, Matthew H.
    PANCREAS, 2016, 45 (03) : 483 - 483
  • [5] Changes in Tumor-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    Weber, M.
    Pettersson, O.
    Seifert, R.
    Schaarschmidt, B. M.
    Fendler, W. P.
    Rischpler, C.
    Lahner, H.
    Herrmann, K.
    Sundin, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S80 - S80
  • [6] Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival
    Lee, Hyun Jae
    Lee, Min Woo
    Ahn, Soo Hyun
    Cha, Dong Ik
    Ko, Seong Eun
    Kang, Tae Wook
    Song, Kyoung Doo
    Rhim, Hyunchul
    ULTRASONOGRAPHY, 2022, 41 (04) : 728 - 739
  • [7] Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    Manuel Weber
    Olof Pettersson
    Robert Seifert
    Benedikt M. Schaarschmidt
    Wolfgang P. Fendler
    Christoph Rischpler
    Harald Lahner
    Ken Herrmann
    Anders Sundin
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 841 - 851
  • [8] Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    Weber, Manuel
    Pettersson, Olof
    Seifert, Robert
    Schaarschmidt, Benedikt M.
    Fendler, Wolfgang P.
    Rischpler, Christoph
    Lahner, Harald
    Herrmann, Ken
    Sundin, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 841 - 851
  • [9] Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma
    Guzman-Casta, Jordi
    Carrasco-CaraChards, Sonia
    Guzman-Huesca, Jorge
    Sanchez-Rios, Carla Paola
    Riera-Sala, Rodrigo
    Martinez-Herrera, Jose Fabian
    Pena-Mirabal, Erika Sagrario
    Bonilla-Molina, Diana
    Alatorre-Alexander, Jorge Arturo
    Martinez-Barrera, Luis Manuel
    Rodriguez-Cid, Jeronimo Rafael
    THORACIC CANCER, 2021, 12 (07) : 1014 - 1022
  • [10] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Bramuzzo, I.
    Gerussi, A.
    Maier, S.
    Bianco, C.
    Romanin, A.
    Pasini, C. Laghi
    Barghini, V.
    Scata, L.
    Donnini, D.
    Uzzau, A.
    Vit, A.
    Sechi, L. A.
    Soardo, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
12345